Anti-Dectin-2 antibodies
US11753474B2 · kind B2 · utility
0Cited by
1References
131Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2022 |
| Grant date | Sep 12, 2023 |
| Priority date | — |
| Expiry date | Feb 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/75
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to dendritic cell-associated C-type lectin 2 (Dectin-2) binding agents, nucleic acids comprising the inventive binding agents, vectors and cells comprising the inventive nucleic acids, and compositions thereof. The invention also relates to methods of providing the inventive binding agents, methods for treating a disease, disorder, or condition in a mammal, and methods of stimulating an antigen presenting cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.